Best Steven R D, Griffin Brian P, Pavel Dan G
The Neuroscience Center, 440 Lake Cook Road, Building 2, Deerfield, IL, 60015, USA.
Independent Practice, 333 East Ontario Suite 1203B, Chicago, IL, USA.
J Med Case Rep. 2015 Mar 31;9:73. doi: 10.1186/s13256-015-0520-0.
To the best of our knowledge, this is the first case report of successful treatment for bipolar II disorder using a combined ketamine and transcranial magnetic stimulation treatment.
A 43-year-old Caucasian unemployed man presented to us with treatment-resistant bipolar II disorder, currently in a mixed state. A psychometric assessment and brain single-photon emission computer tomography scan were conducted at baseline. His psychometric assessment revealed severe depressive and manic symptoms that were consistent with bipolar II disorder. Findings from a brain single-photon emission computer tomography scan converged with those from his psychometric assessment. The combined ketamine and transcranial magnetic stimulation treatment was administered a total of 24 times over five months, with his ketamine dosage increased from 50mg at the first treatment to 600 mg by the last. Starting after the second treatment, he reported substantial improvements in his symptoms. A follow-up psychometric assessment and brain single-photon emission computer tomography scan five months later revealed substantial blood flow increases in the previously deficient areas.
We provide preliminary evidence for a treatment method that magnifies the therapeutic benefits of infused ketamine along with transcranial magnetic stimulation. We postulate that this may be based on an interaction at the level of the relevant cortico-thalamo-cortical circuit(s).
据我们所知,这是首例使用氯胺酮联合经颅磁刺激治疗双相II型障碍取得成功的病例报告。
一名43岁的失业白人男性因难治性双相II型障碍前来就诊,目前处于混合状态。在基线时进行了心理测评和脑部单光子发射计算机断层扫描。他的心理测评显示出严重的抑郁和躁狂症状,与双相II型障碍相符。脑部单光子发射计算机断层扫描的结果与他的心理测评结果一致。氯胺酮联合经颅磁刺激治疗在五个月内共进行了24次,氯胺酮剂量从首次治疗时的50毫克增加到最后一次的600毫克。从第二次治疗开始,他报告症状有显著改善。五个月后的随访心理测评和脑部单光子发射计算机断层扫描显示,先前供血不足的区域血流量大幅增加。
我们为一种放大静脉注射氯胺酮与经颅磁刺激治疗效果的治疗方法提供了初步证据。我们推测这可能基于相关皮质-丘脑-皮质回路水平的相互作用。